Nicotine
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Mar 1, 2008 → May 1, 2008
NCT ID
NCT01152723About Nicotine
Nicotine is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01152723. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01152736 | Pre-clinical | Completed |
| NCT01152723 | Pre-clinical | Completed |
Competing Products
20 competing products in Tobacco Dependence